Skip to main content
NIH funding notice RFA-HL-23-010

Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed)

Closed on November 22, 2024.

Posted
January 24, 2022
Close date
November 22, 2024
Activity codes
R33
Institutes taking part
NHLBI

The notices it replaced

1 notice since 2019, oldest first, each with its awards since FY2014.

  1. Posted 2019RFA-HL-20-02211 awards
  2. Posted 2022RFA-HL-23-010This notice, closed · 9 awards

Replaced by RFA-HL-26-016.

Who won it before

Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.

Past awards
20
20 new
Median first-year cost
$477,623
$9,459,374 in all
Institutions
19
20 contact PIs

Awards by fiscal year

Fiscal years 2014 to 2026.

Most frequent institutions

  1. BRIGHAM AND WOMEN'S HOSPITAL2
  2. ALBERT EINSTEIN COLLEGE OF MEDICINE1
  3. HUGO W. MOSER RES INST KENNEDY KRIEGER1
  4. MASSACHUSETTS GENERAL HOSPITAL1
  5. NORTHWESTERN UNIVERSITY AT CHICAGO1

and 14 other institutions

Most frequent study sections

  1. Special Emphasis Panel (ZHL1 CSR-O (O1))6
  2. Special Emphasis Panel (ZHL1 CSR-O (F1))3
  3. Special Emphasis Panel (ZHL1 CSR-O (M2))3
  4. Special Emphasis Panel (ZHL1 CSR-O (F2))2
  5. Special Emphasis Panel (ZHL1 CSR-O (J1))2

and 3 other study sections

20 awards under RFA-HL-23-010 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
FY2025Drug Coated Balloon Peptide Delivery to Block Post-angioplasty Restenosis in PAD1R33HL181752-01Duvall, Craig LewisVANDERBILT UNIVERSITY, TNFirst-year cost $489,644Study section ZHL1
FY2025Development of platform technology to measure kinetics and equilibrium concentration of sickle hemoglobin polymerization in single RBCs for drug potency assessment and patient risk stratification1R33HL173898-01A1Higgins, John MatthewMASSACHUSETTS GENERAL HOSPITAL, MAFirst-year cost $483,852Study section ZHL1
FY2024Flexible bioelectronics platform converging capillary-like delivery network and sensing feedback network for improving cardiac tissue engineering1R33HL175683-01Yao, JunUNIVERSITY OF MASSACHUSETTS AMHERST, MAFirst-year cost $488,026Study section ZHL1
FY2024A Novel Ticagrelor Coated Stent to Eliminate the Need for Dual Anti Platelet Therapy Post PCI1R33HL171775-01Pacella, John JUNIVERSITY OF PITTSBURGH AT PITTSBURGH, PAFirst-year cost $481,245Study section ZHL1
FY2024Advancement of an Impending Hospitalization Detection Platform1R33HL168785-01A1King, Kevin RUNIVERSITY OF CALIFORNIA, SAN DIEGO, CAFirst-year cost $474,000Study section ZHL1
FY2024Towards systematic analysis of cardiac voltage-gated sodium channel beta subunit function1R33HL168768-01A1Ahern, Christopher APiper, Robert CUNIVERSITY OF IOWA, IAFirst-year cost $466,355Study section ZHL1
FY2023A New Lipid Nanoparticle Technology Enabling Long-acting mRNA Therapy1R33HL168751-01Shi, JinjunBRIGHAM AND WOMEN'S HOSPITAL, MAFirst-year cost $542,677Study section ZHL1
FY2023Optimization of electromechanical monitoring of engineered heart tissues1R33HL168758-01Efimov, Igor RMcNally, Elizabeth MRogers, JohnNORTHWESTERN UNIVERSITY AT CHICAGO, ILFirst-year cost $466,698Study section ZHL1
FY2023High throughput platform for simultaneous multiparametric assessment of cardiac physiology for heart failure drug development1R33HL167258-01A1Mercola, MarkSTANFORD UNIVERSITY, CAFirst-year cost $463,200Study section ZHL1
FY2022The genetically engineered pig heart as a bridge to allotransplantation in infants1R33HL163718-01 · under RFA-HL-20-022Cleveland, David CUNIVERSITY OF ALABAMA AT BIRMINGHAM, ALFirst-year cost $488,333Study section ZHL1
FY2022MPI/MRI bimodal imaging for non-invasive tracking of extracellular vesicles targeted to infarcted myocardium1R33HL161756-01 · under RFA-HL-20-022Liu, GuanshuHUGO W. MOSER RES INST KENNEDY KRIEGER, MDFirst-year cost $487,071Study section ZHL1
FY2022Hyperpolarized Carbon-13 Metabolic MRI of the Human Heart1R33HL161816-01 · under RFA-HL-20-022Abraham, Maria RoselleLarson, Peder Eric ZufallUNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CAFirst-year cost $482,538Study section ZHL1
FY2022Beat-to-Beat Blood Pressure Monitoring During Sleep1R33HL163749-01 · under RFA-HL-20-022Kim, JoshuaVENA VITALS, INC., CAFirst-year cost $415,577Study section ZHL1
FY2022An Enabling Technology for Human Cardiomyocyte Manufacturing1R33HL163711-01 · under RFA-HL-20-022Lei, YuguoPENNSYLVANIA STATE UNIVERSITY, THE, PAFirst-year cost $413,610Study section ZHL1
FY2021Exhaled small RNA biomarkers to detect and monitor airway disease1R33HL156279-01 · under RFA-HL-20-022Loudig, OlivierSpivack, Simon DALBERT EINSTEIN COLLEGE OF MEDICINE, NYFirst-year cost $532,716Study section ZHL1
FY2021Dynamic tissue-specific modulation of redox stress using chemogenetics1R33HL157918-01 · under RFA-HL-20-022Michel, ThomasBRIGHAM AND WOMEN'S HOSPITAL, MAFirst-year cost $513,644Study section ZHL1
FY2021Developing EPR tools for preclinical interrogation of redox regulation mechanisms contributing to acute lung injury1R33HL157907-01 · under RFA-HL-20-022Eaton, Sandra S.Nozik, Eva S.UNIVERSITY OF COLORADO DENVER, COFirst-year cost $409,657Study section ZHL1
FY2020An inflammation-induced fibrosis-on-chip system for the testing of anti-fibrosis drugs1R33HL154117-01 · under RFA-HL-20-022Zhao, RuogangSTATE UNIVERSITY OF NEW YORK AT BUFFALO, NYFirst-year cost $460,967Study section ZHL1
FY2020Development of a next-generation glycomics platform to enable glycan structure analyses for precision medicine1R33HL154123-01 · under RFA-HL-20-022Gundry, Rebekah L.UNIVERSITY OF NEBRASKA MEDICAL CENTER, NEFirst-year cost $458,564Study section ZHL1
FY2020Optimization of a Rabbit Retained Hemothorax Model for Evidence-Based Pharmacologic Interventions1R33HL154103-01 · under RFA-HL-20-022Florova, GalinaIdell, StevenKomissarov, AndreyUNIVERSITY OF TEXAS HLTH CTR AT TYLER, TXFirst-year cost $441,000Study section ZHL1
Newest fiscal year first, then first-year cost.

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-13-0.3.2. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for departments

Open NIH notices that fit your faculty

See which open NIH funding notices fit each faculty member's CV, why each fits, and who won before.